Gabrielle Moisan and Danièle Éthier Appointed as Partners of the Firm
On April 1, 2012, the firm announced the nomination of two new partners from its patent sector.
Gabrielle Moisan is a lawyer, biochemist and patent agent specialized in the drafting and prosecution of patent applications and providing patentability, validity, infringement and freedom to operate opinions in the fields of life sciences and pharmaceutics.
While pursuing her biochemistry degree Ms Moisan undertook research internships studying the molecular biology of plants at Université de Montréal and oncogenic viruses at the Pasteur Institute in Paris. She later completed a Masters in cellular biology at the Cancer Institute of Montreal focussing on lung cancer.
Ms Moisan participated in an exchange program with Université La Sorbonne in Paris and then went on to obtain her Patents and Trademarks Diploma from the Centre for International Industrial Property Studies (CEIPI) in Strasbourg, France, one of Europe’s most recognised institutions of higher learning specialised in the field of intellectual property.
Ms Moisan joined the firm in 1998 following which she also worked in the pharmaceutical industry where she managed a substantial patent and trademark portfolio in the global intellectual property group of a pharmaceutical company in the fields of antiviral and vaccine technologies and before returning to ROBIC in 2008. She is a member of the firm’s life sciences committee, the corporate and transactional committee and the continuing education committee. She is assistant editor of ROBIC’s quarterly newsletter and is particularly active in the French Chamber of Commerce in Canada and the Intellectual Property Institute of Canada (IPIC).
Danièle Éthier is a biochemist and patent agent specialized in the drafting and prosecution of patent applications, and providing patentability, validity, infringement and freedom to operate opinions in the field of life sciences. She has a particular expertise in strategic planning, worldwide patent prosecutions, pharmaceutical product life cycle management and due diligence matters.
Ms Éthier has more than 18 years of experience in the field of intellectual property. Prior to joining ROBIC, she held the position of Director, Intellectual Property in an important antiviral research company where she managed a substantial patent portfolio. She also held a similar position in the global intellectual property group of a pharmaceutical company in the fields of antiviral and vaccine technologies.
She joined the patent sector of the firm in 2010. She chairs the life science committee and is a member of the practice committee. Recently, she has played an important role in a project on internal processes.